Preparation and characterization of a hormone-responsive renal plasma membrane fraction.
D000251:Adenosine Triphosphatases / Q000302:isolation & purification; D000067956:Adenylyl Cyclase Inhibitors; D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D002116:Calcitonin / Q000378:metabolism / Q000494:pharmacology*; D002417:Cattle; D002462:Cell Membrane / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D002499:Centrifugation, Density Gradient; D004789:Enzyme Activation; D007456:Iodine Isotopes; D007545:Isoproterenol / Q000494:pharmacology*; D007668:Kidney / Q000166:cytology / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D008297:Male; D010281:Parathyroid Hormone / Q000494:pharmacology*; D010759:Phosphorus Isotopes; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D014316:Tritium; D014667:Vasopressins / Q000494:pharmacology*
D000067956:Adenylyl Cyclase Inhibitors; D007456:Iodine Isotopes; D010281:Parathyroid Hormone; D010759:Phosphorus Isotopes; D014316:Tritium; D014667:Vasopressins; D002116:Calcitonin; D011433:Propranolol; D000251:Adenosine Triphosphatases; D000262:Adenylyl Cyclases; D007545:Isoproterenol